InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.34
(
-0.01%
)
US TECH 100
17,606.79
(
-0.03%
)
Dow Jones
39,058.41
(
0.45%
)
Brent Oil
83.57
(
0.85%
)
Bitcoin
62,148.30
(
-0.30%
)
Post# of 2338538
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Covid19freak

Send PM Follow Ignore
Followers 10
Posts 1249
Boards Moderated 0
Alias Born 07/20/2020

Covid19freak

Re: None

Monday, 07/10/2023 11:22:57 AM

Monday, July 10, 2023 11:22:57 AM

Post# of 2338538
(KOD) $7 - 3x Ph 3 data in JULY and the company still trades under cash, risky gem but if the drug is successful then this has huge upside because of its very large market potential

"We are on the cusp of four Phase 3 study readouts in major indications, starting with results of our GLEAM, GLIMMER and DAYLIGHT studies expected in July and our GLOW study in September. Following our successful pivotal study readout in retinal vein occlusion last year, we look forward to unmasking the primary endpoint data in these next four studies shortly"

presentation
https://ir.kodiak.com/static-files/837c8ad5-44f2-429f-a91e-b0e96463402d
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up